Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Borderline and malignant phyllodes tumors display similar promoter methylation profiles.

Kim JH, Choi YD, Lee JS, Lee JH, Nam JH, Choi C, Park MH, Yoon JH.

Virchows Arch. 2009 Dec;455(6):469-75. doi: 10.1007/s00428-009-0858-z. Epub 2009 Nov 19.

PMID:
19924440
2.

DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast.

Huang KT, Dobrovic A, Yan M, Karim RZ, Lee CS, Lakhani SR, Fox SB.

Breast Cancer Res Treat. 2010 Nov;124(2):555-65. doi: 10.1007/s10549-010-0970-4. Epub 2010 Jun 19.

PMID:
20563638
3.

Quantitative assessment of DNA hypermethylation in the inflammatory and non-inflammatory breast cancer phenotypes.

Van der Auwera I, Bovie C, Svensson C, Limame R, Trinh XB, van Dam P, Van Laere SJ, Van Marck E, Vermeulen PB, Dirix LY.

Cancer Biol Ther. 2009 Dec;8(23):2252-9. Epub 2009 Dec 19.

PMID:
19829046
4.

Expression of TWIST1, Snail, Slug, and NF-κB and methylation of the TWIST1 promoter in mammary phyllodes tumor.

Do SI, Kim JY, Kang SY, Lee JJ, Lee JE, Nam SJ, Cho EY.

Tumour Biol. 2013 Feb;34(1):445-53. doi: 10.1007/s13277-012-0569-y. Epub 2012 Nov 14.

PMID:
23150175
5.

Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.

Sharma G, Mirza S, Parshad R, Srivastava A, Gupta SD, Pandya P, Ralhan R.

Life Sci. 2010 Jul 17;87(3-4):83-91. doi: 10.1016/j.lfs.2010.05.001. Epub 2010 May 12.

PMID:
20470789
6.

Promoter hypermethylation profile of ovarian epithelial neoplasms.

Makarla PB, Saboorian MH, Ashfaq R, Toyooka KO, Toyooka S, Minna JD, Gazdar AF, Schorge JO.

Clin Cancer Res. 2005 Aug 1;11(15):5365-9.

7.

DNA hypermethylation status of multiple genes in soft tissue sarcomas.

Kawaguchi K, Oda Y, Saito T, Yamamoto H, Takahira T, Kobayashi C, Tamiya S, Tateishi N, Iwamoto Y, Tsuneyoshi M.

Mod Pathol. 2006 Jan;19(1):106-14.

8.

Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.

Zou XP, Zhang B, Zhang XQ, Chen M, Cao J, Liu WJ.

Hum Pathol. 2009 Nov;40(11):1534-42. doi: 10.1016/j.humpath.2009.01.029. Epub 2009 Aug 19.

PMID:
19695681
9.

GSTP1 promoter hypermethylation is an early event in breast carcinogenesis.

Lee JS.

Virchows Arch. 2007 Jun;450(6):637-42. Epub 2007 May 4. Erratum in: Virchows Arch. 2007 Sep;451(3):741.

PMID:
17479284
10.

Very high frequency of hypermethylated genes in breast cancer metastasis to the bone, brain, and lung.

Mehrotra J, Vali M, McVeigh M, Kominsky SL, Fackler MJ, Lahti-Domenici J, Polyak K, Sacchi N, Garrett-Mayer E, Argani P, Sukumar S.

Clin Cancer Res. 2004 May 1;10(9):3104-9.

11.

Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer.

Hoque MO, Feng Q, Toure P, Dem A, Critchlow CW, Hawes SE, Wood T, Jeronimo C, Rosenbaum E, Stern J, Yu M, Trink B, Kiviat NB, Sidransky D.

J Clin Oncol. 2006 Sep 10;24(26):4262-9. Epub 2006 Aug 14.

12.

Evaluation of promoter hypermethylation detection in serum as a diagnostic tool for breast carcinoma in Korean women.

Kim JH, Shin MH, Kweon SS, Park MH, Yoon JH, Lee JS, Choi C, Fackler MJ, Sukumar S.

Gynecol Oncol. 2010 Aug 1;118(2):176-81. doi: 10.1016/j.ygyno.2010.04.016. Epub 2010 May 13.

PMID:
20466412
13.

A comprehensive genetic profile of phyllodes tumours of the breast detects important mutations, intra-tumoral genetic heterogeneity and new genetic changes on recurrence.

Jones AM, Mitter R, Springall R, Graham T, Winter E, Gillett C, Hanby AM, Tomlinson IP, Sawyer EJ; Phyllodes Tumour Consortium.

J Pathol. 2008 Apr;214(5):533-44. doi: 10.1002/path.2320.

PMID:
18288784
14.
15.

Correlation between promoter hypermethylation of GSTP1 and response to chemotherapy in diffuse large B cell lymphoma.

Nakamichi I, Tomita Y, Zhang B, Sugiyama H, Kanakura Y, Fukuhara S, Hino M, Kanamaru A, Ogawa H, Aozasa K.

Ann Hematol. 2007 Aug;86(8):557-64. Epub 2007 May 17.

PMID:
17508213
16.

Inactivation of RASSF1A, RARbeta2 and DAP-kinase by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma.

Fendri A, Masmoudi A, Khabir A, Sellami-Boudawara T, Daoud J, Frikha M, Ghorbel A, Gargouri A, Mokdad-Gargouri R.

Cancer Biol Ther. 2009 Mar;8(5):444-51. Epub 2009 Mar 21.

PMID:
19221469
17.

Gene promoter hypermethylation in ductal lavage fluid from healthy BRCA gene mutation carriers and mutation-negative controls.

Locke I, Kote-Jarai Z, Fackler MJ, Bancroft E, Osin P, Nerurkar A, Izatt L, Pichert G, Gui GP, Eeles RA.

Breast Cancer Res. 2007;9(1):R20.

18.

mRNA expression profiling of phyllodes tumours of the breast: identification of genes important in the development of borderline and malignant phyllodes tumours.

Jones AM, Mitter R, Poulsom R, Gillett C, Hanby AM, Tomlinson IP, Sawyer EJ; Phyllodes Tumour Consortium.

J Pathol. 2008 Dec;216(4):408-17. doi: 10.1002/path.2439.

PMID:
18937276
19.

Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential.

Wiley A, Katsaros D, Chen H, Rigault de la Longrais IA, Beeghly A, Puopolo M, Singal R, Zhang Y, Amoako A, Zelterman D, Yu H.

Cancer. 2006 Jul 15;107(2):299-308.

20.

Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk.

Lewis CM, Cler LR, Bu DW, Zöchbauer-Müller S, Milchgrub S, Naftalis EZ, Leitch AM, Minna JD, Euhus DM.

Clin Cancer Res. 2005 Jan 1;11(1):166-72.

Items per page

Supplemental Content

Write to the Help Desk